Evidence map›Paper›PMID 35165175›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2022

APT1-Mediated Depalmitoylation Regulates Hippocampal Synaptic Plasticity.

Zu-Cheng Shen, Zhi-Xuan Xia, Jian-Min Liu, Jie-Yan Zheng, Yu-Fei Luo, Han Yang, Meng-Die Li, Ting Cao, Hai-Ping Liu, Gui-Lin Jin and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Profiling the landscape of cysteine posttranslational modifications in brain aging and neurodegeneration.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  6. Article
  7. Palmitoylation in cardiovascular diseases: Molecular mechanism and therapeutic potential.International journal of cardiology. Heart & vasculature · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Zu-Cheng ShenDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Zhi-Xuan XiaDepartment of Pharmacology, School of Basic Medicine and Life Science, Hainan Medical University, Haikou, 571199, China.
Jian-Min LiuDepartment of Pharmacy, Wuhan No. 1 Hospital, Wuhan, 430000, China.
Jie-Yan ZhengGuangdong Provincial Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
Yu-Fei LuoDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Han YangTranslational Medicine Center, Xi'an Chest Hospital, Medical College of Xi'an Jiaotong University, Xi'an, 710100, China.
Meng-Die LiDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Ting CaoDepartment of Children's Stomatology, Stomatological Hospital, Affiliated to Xiamen Medical College, Xiamen, 361003, China.
Hai-Ping LiuDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Gui-Lin JinDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Hui-Hui HuangDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Chang-Xi YuDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China zhoujun2364@163.com changxiyu@mail.fjmu.edu.cn.
Jun ZhouTranslational Medicine Center, Xi'an Chest Hospital, Medical College of Xi'an Jiaotong University, Xi'an, 710100, China zhoujun2364@163.com changxiyu@mail.fjmu.edu.cn.ORCID 0000-0001-7628-3367
Fujian Medical University · CNHainan Medical University · CNStomatology Hospital · CNSun Yat-sen University · CNWuhan No.1 Hospital · CNXi'an Chest Hospital · CNXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Palmitoylation may be relevant to the processes of learning and memory, and even disorders, such as post-traumatic stress disorder and aging-related cognitive decline. However, underlying mechanisms of palmitoylation in these processes remain unclear. Herein, we used acyl-biotin exchange, coimmunoprecipitation and biotinylation assays, and behavioral and electrophysiological methods, to explore whether palmitoylation is required for hippocampal synaptic transmission and fear memory formation, and involved in functional modification of synaptic proteins, such as postsynapse density-95 (PSD-95) and glutamate receptors, and detected if depalmitoylation by specific enzymes has influence on glutamatergic synaptic plasticity. Our results showed that global palmitoylation level, palmitoylation of PSD-95 and glutamate receptors, postsynapse density localization of PSD-95, surface expression of AMPARs, and synaptic strength of cultured hippocampal neurons were all enhanced by TTX pretreatment, and these can be reversed by inhibition of palmitoylation with palmitoyl acyl transferases inhibitors, 2-bromopalmitate and N-(tert-butyl) hydroxylamine hydrochloride. Importantly, we also found that acyl-protein thioesterase 1 (APT1)-mediated depalmitoylation is involved in palmitoylation of PSD-95 and glutamatergic synaptic transmission. Knockdown of APT1, not protein palmitoyl thioesterase 1, with shRNA, or selective inhibition, significantly increased AMPAR-mediated synaptic strength, palmitoylation levels, and synaptic or surface expression of PSD-95 and AMPARs. Results from hippocampal tissues and fear-conditioned rats showed that palmitoylation is required for synaptic strengthening and fear memory formation. These results suggest that palmitoylation and APT1-mediated depalmitoylation have critical effects on the regulation of glutamatergic synaptic plasticity, and it may serve as a potential target for learning and memory-associated disorders.

Indexed as

HippocampusSynapsesAnimalsMiceMice, Inbred C57BLNeuronal PlasticityRatsSynaptic TransmissionAPT1fear conditioningglutamate receptorspalmitoylationPSD-95synaptic plasticity

Identifiers

PMID35165175
PMCPMC8973429
OpenAlexW4213086718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.